20 results
8-K
EX-1.1
AQST
Aquestive Therapeutics Inc
21 Mar 24
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
4:06pm
in debarment, suspension or exclusion.
(xxxi) Privacy and Data Protection. Except as would not, individually or in the aggregate, reasonably … of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
8-K
EX-4.1
AQST
Aquestive Therapeutics Inc
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
software (including source code, executable code, data, databases, and related documentation); (vi) all rights of privacy and publicity, including rights
8-K
EX-10.1
wy1k fdb2n0e3
8 Jun 22
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
4:22pm
8-K
EX-1.1
44u2l
16 Dec 19
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
5:26pm
S-3
EX-1.2
z2be4lu4 61t4u
11 Sep 19
Shelf registration
5:21pm
8-K
EX-4.1
ogvm7uy1q
16 Jul 19
Aquestive Therapeutics Completes $70 Million Debt Refinancing
12:00am
10-K
5wn5i2rvb mncd5m6x
14 Mar 19
Annual report
2:04pm
424B4
12ehp8oq7kg
26 Jul 18
Prospectus supplement with pricing info
4:52pm
CORRESP
bck7r80 bopcqmvf48if
28 Jun 18
Correspondence with SEC
12:00am
DRS/A
szk3nf1absxtkgi0ol
22 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next